INSTRUCTIONS Asthma in pregnancy: Reading between the lines
* To take the test online, go to our secure Web site at http://www.nursingcenter.com/ce/NP.
* On the print form, record your answers in the test answer section of the CE enrollment form on page 20. Each question has only one correct answer. You may make copies of these forms.
* Complete the registration information and course evaluation. Mail the completed form and registration fee of $24.95 to: Lippincott Williams & Wilkins, CE Group, 2710 Yorktowne Blvd., Brick, NJ 08723. We will mail your certificate in 4 to 6 weeks. For faster service, include a fax number and we will fax your certificate within 2 business days of receiving your enrollment form.
* You will receive your CE certificate of earned contact hours and an answer key to review your results. There is no minimum passing grade.
* Registration deadline is April 30, 2012.
DISCOUNTS and CUSTOMER SERVICE
* Send two or more tests in any nursing journal published by Lippincott Williams & Wilkins together and deduct $0.95 from the price of each test.
* We also offer CE accounts for hospitals and other healthcare facilities on nursingcenter.com. Call 1-800-787-8985 for details.
Lippincott Williams & Wilkins, publisher of The Nurse Practitioner journal, will award 2.6 contact hours for this continuing nursing education activity.
Lippincott Williams & Wilkins is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749 for 2.6 contact hours. Lippincott Williams & Wilkins is also an approved provider of continuing nursing education by the District of Columbia and Florida #FBN2454.
Your certificate is valid in all states. This activity has been assigned 0.5 credit hour.
The ANCC's accreditation status of Lippincott Williams & Wilkins Department of Continuing Education refers only to its continuing nursing educational activities and does not imply Commission on Accreditation approval or endorsement of any commercial product.
Asthma in pregnancy: Reading between the lines
General Purpose: To provide the NP with an overview of the management of asthma during pregnancy. Learning Objectives: After reading the article and taking the following test, you should be able to: 1. Describe the assessment process and findings of asthma during pregnancy. 2. Illustrate the appropriate management and control of asthma during pregnancy and lactation.
1. To confirm the diagnosis of asthma, perform
a. a chest X-ray.
b. a magnetic resonance imaging scan.
c. a PET scan following a nebulized dose of a SABA.
d. pre- and postbronchodilation spirometry.
2. When your pregnant patient has dyspnea,
a. airway obstruction is the usual cause.
b. reduced FEV1 is an expected finding.
c. spirometry is a useful tool to evaluate most patients for asthma.
d. methacholine challenge testing is done if spirometry is normal.
3. For patients classified as mild persistent asthmatics, initiate treatment at step
4. A patient with moderate asthma will have all the following except
a. daily symptoms.
b. 5% reduction in FEV1/FVC.
c. nighttime awakenings.
d. daily use of SABA for symptom control.
5. The preferred medication treatment during step 3 for persistent asthma is
a. low-dose ICS alone.
b. low-dose ICS and LABA.
c. medium-dose ICS and LTRA.
d. high-dose ICS and LABA.
6. During pregnancy, pulmonary function testing and asthma control assessment are recommended every
c. other month.
d. 3 months.
7. Which is a preferred rescue medication during pregnancy?
8. Which statement is accurate about the use of a SABA for rescue therapy?
a. It should not be initiated until there is a 40% decline in peak flow readings.
b. Two to six puffs of an MDI initially, and treatment repeated 20 minutes later if symptoms persist.
c. Lack of adequate response indicates need for a LABA.
d. If symptoms are alleviated, continue SABA hourly for 4 to 6 hours.
9. Which patient report is not an indication for a step-up in asthma therapy?
a. asthma symptoms 1 day per week
b. nighttime awakenings due to asthma more than twice a month
c. use of rescue SABA more than 2 days per week
d. limitations in activities
10. The preferred controller medication for persistent asthma symptoms during pregnancy is
11. Which medication carries the pregnancy risk category B?
12. If not controlled on a medium-dose ICS alone, the next recommended add-on therapy is
a. SABA combined with theophylline.
b. SABA combined with oral corticosteroids.
c. LABA combined with mast cell stabilizers.
d. LABA combined with ICS.
13. Patients may initially treat asthma exacerbations at home with two treatments of
a. LABA, two to six puffs 20 minutes apart.
b. SABA, one to two puffs 60 minutes apart.
c. SABA, two to six puffs 20 minutes apart.
d. LTRA, two to six puffs 30 minutes apart.
14. Which is a criterion for admission to the hospital?
a. Paco2 over 42 mm Hg
b. FEV1 60% of predicted
c. a second dose of SABA is needed
d. a patient with persistent wheezing
15. After hospitalization for an acute asthma exacerbation, medications should include a prn SABA and
a. ICS, two to four puffs every 6 to 8 hours.
d. oral corticosteroids.
16. Which statement is true about labor and delivery for patients with asthma?
a. Discontinue asthma medications 1 week before delivery.
b. Lumbar anesthesia can increase oxygen consumption.
c. Cesarean sections are frequently needed for acute exacerbations.
d. Hydrocortisone during labor and 24 hours afterward is recommended for high-risk patients.
17. Paradoxical central nervous stimulation in breastfeeding infants has been associated with maternal use of
d. beta2 agonists.